APTYS PHARMACEUTICALS Revenue and Competitors
Estimated Revenue & Valuation
- APTYS PHARMACEUTICALS's estimated annual revenue is currently $4.4M per year.
- APTYS PHARMACEUTICALS's estimated revenue per employee is $201,000
Employee Data
- APTYS PHARMACEUTICALS has 22 Employees.
APTYS PHARMACEUTICALS's People
| Name | Title | Email/Phone |
|---|
APTYS PHARMACEUTICALS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is APTYS PHARMACEUTICALS?
APTYS is a CRDO (contract research and development organization) which develops innovative products based of its expertise in pharmaceutical technologies and peptide delivery. APTYS offers ISO9001 aligned contract service, according to cGMP.  Custom-made formulation development including in vivo/in vitro assessments.  Semi solid dosage forms for topical and transdermal delivery.  Injectable peptide depot formulations.  Analytical development and validations.  Quality control and ICH stability.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$4.4M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Saint-Beauzire
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $288.4M | 763 | 5% | N/A |
#2 | $3631.8M | 9608 | 9% | N/A |